| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 保护剂系列(元) | 4,421,820.86 | 2,419,929.10 | 4,735,003.55 | 2,213,201.71 |
| 医药中间体及原料药(元) | 251,864,234.55 | 138,020,182.33 | 133,089,076.28 | 68,447,186.52 |
| 受托加工服务(元) | 1,022,123.89 | - | 1,266,469.52 | - |
| 营业成本(元) | ||||
| 保护剂系列(元) | 3,745,396.90 | 2,163,383.79 | 3,995,194.43 | 1,769,224.36 |
| 医药中间体及原料药(元) | 126,675,233.55 | 60,280,209.72 | 102,845,356.78 | 52,603,076.06 |
| 受托加工服务(元) | 723,306.72 | - | 1,586,575.79 | - |
| 毛利(元) | ||||
| 保护剂系列(元) | 676,423.96 | 256,545.31 | 739,809.12 | 443,977.35 |
| 医药中间体及原料药(元) | 125,189,001.00 | 77,739,972.61 | 30,243,719.50 | 15,844,110.46 |
| 受托加工服务(元) | 298,817.17 | - | -320,106.27 | - |
| 毛利率(%) | ||||
| 保护剂系列(%) | 15.30 | 10.60 | 15.62 | 20.06 |
| 医药中间体及原料药(%) | 49.70 | 56.33 | 22.72 | 23.15 |
| 受托加工服务(%) | 29.23 | - | -25.28 | - |
| 收入构成(%) | ||||
| 保护剂系列(%) | 1.72 | 1.72 | 3.40 | 3.13 |
| 医药中间体及原料药(%) | 97.88 | 98.28 | 95.69 | 96.87 |
| 受托加工服务(%) | 0.40 | - | 0.91 | - |
| 毛利构成(%) | ||||
| 保护剂系列(%) | 0.54 | 0.33 | 2.41 | 2.73 |
| 医药中间体及原料药(%) | 99.23 | 99.67 | 98.63 | 97.27 |
| 受托加工服务(%) | 0.24 | - | -1.04 | - |